» Articles » PMID: 29516236

Association of TNF-α-308(G/A) and -238(G/A) Polymorphisms with Non-traumatic Osteonecrosis of the Femoral Head Risks: a Meta-analysis

Overview
Journal Int Orthop
Specialty Orthopedics
Date 2018 Mar 9
PMID 29516236
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The association between TNF-α-308(G/A) and -238(G/A) polymorphisms and the susceptibility of non-traumatic osteonecrosis of the femoral head (NONFH) was investigated in many studies with conflicting results. We aimed to conduct a meta-analysis to evaluate the relationship between them comprehensively.

Methods: Relevant literatures published in PubMed, Web of Science, Embase, Cochrane library databases, China National Knowledge Infrastructure (CNKI), WANFANG Data, and China Science and Technology Journal Database (CSTJ) updated to January 30, 2018, were reviewed by two investigators independently. Odds ratios (ORs) and its 95% confidence intervals (95% CIs) were calculated by a fixed-effect model based on the indistinctive heterogeneity.

Results: For TNF-α-308(G/A) polymorphism, we recruited five studies including 432 NONFH patients and 760 controls and a statistically significant association was identified in Asians in four modes consisting of alleles mode (OR = 0.648, 95% CI 0.475-0.885), homozygote mode (OR = 0.330, 95% CI 0.136-0.802), dominant mode (OR = 0.344, 95% CI 0.143-0.827), and recessive mode (OR = 0.674, 95% CI 0.468-0.971), but no significant association was observed in Caucasians. For TNF-α-238(G/A) polymorphism, three eligible studies including 275 cases and 610 controls were evaluated and there was a significant association in alleles mode (OR = 0.270, 95% CI 0.4148-0.490) as well as recessive mode (OR = 0.254, 95% CI 0.138-0.468).

Conclusion: This meta-analysis shows that TNF-α-308(G/A) and -238(G/A) polymorphisms are associated with the susceptibility of NONFH, while the significant association for 308(G/A) is mainly observed in Asians.

Citing Articles

Integrative analyses of genes related to femoral head osteonecrosis: an umbrella review of systematic reviews and meta-analyses of observational studies.

Lee S, Yoo J, Kang Y J Orthop Surg Res. 2022; 17(1):182.

PMID: 35346283 PMC: 8961967. DOI: 10.1186/s13018-022-03079-4.


An intron SNP rs2069837 in IL-6 is associated with osteonecrosis of the femoral head development.

Wang R, Li R, Liu R BMC Med Genomics. 2022; 15(1):5.

PMID: 34986839 PMC: 8734317. DOI: 10.1186/s12920-021-01142-3.


[Predictive effect of femoral neck strength composite indexes on femoral head collapse in non-traumatic osteonecrosis of femoral head].

Lin T, Yang P, Cai K, Li Z, Pang F, Zhang Q Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2021; 35(8):967-972.

PMID: 34387423 PMC: 8403992. DOI: 10.7507/1002-1892.202103168.


Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A 5-Year Update.

Mont M, Salem H, Piuzzi N, Goodman S, Jones L J Bone Joint Surg Am. 2020; 102(12):1084-1099.

PMID: 32282421 PMC: 7508290. DOI: 10.2106/JBJS.19.01271.


Osteonecrosis of the femoral head: genetic basis.

Wang T, Azeddine B, Mah W, Harvey E, Rosenblatt D, Seguin C Int Orthop. 2018; 43(3):519-530.

PMID: 30328481 DOI: 10.1007/s00264-018-4172-8.


References
1.
Zou W, Yang S, Zhang T, Sun H, Wang Y, Xue H . Hypoxia enhances glucocorticoid-induced apoptosis and cell cycle arrest via the PI3K/Akt signaling pathway in osteoblastic cells. J Bone Miner Metab. 2014; 33(6):615-24. DOI: 10.1007/s00774-014-0627-1. View

2.
Filipowska J, Tomaszewski K, Niedzwiedzki L, Walocha J, Niedzwiedzki T . The role of vasculature in bone development, regeneration and proper systemic functioning. Angiogenesis. 2017; 20(3):291-302. PMC: 5511612. DOI: 10.1007/s10456-017-9541-1. View

3.
Wang S, Wei M, Han Y, Zhang K, He L, Yang Z . Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study. BMC Infect Dis. 2008; 8:27. PMC: 2291466. DOI: 10.1186/1471-2334-8-27. View

4.
Dai C, Chuang W, Lee L, Chen S, Hou N, Lin Z . Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C. J Viral Hepat. 2006; 13(11):770-4. DOI: 10.1111/j.1365-2893.2006.00767.x. View

5.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View